The US asthma therapeutics market is shaped by competition between branded medicines, generic inhalers, and emerging therapies. Manufacturers focus on clinical effectiveness, delivery-device usability, dosing convenience, and differentiation as healthcare providers consider treatment options and payers assess coverage. The asthma therapeutics market is projected to reach US$ 37.86 billion by...